Ads
-
Related paper
- The Influence of Pathogenetic Treatment on Peroxidation in Patients with Ischemic Heart Disease and Comorbid Nonalcoholic Steatohepatitis
- Influence of Levocarnitin Treatment during a Stable Ischemic Heart Disease in Patients with Non-Alcoholic Fatty Liver Disease and Obesity
- Influence of koraksan treatment on vascular wall condition, immunology inflamation and heart rate variability and in patients with ischemic heart disease: stable angina pectoris II-III FC
- Estimation of lipid peroxidation and neurovegetative homeostasis at patients with ischemic heart disease with paroxysmal atrial fibrillation
- Clinical Features of the Course of Non-Alcoholic Steatohepatitis with Comorbid Coronary Heart Disease
- The Influence of Nonalcoholic Fatty Liver Disease on the Platelet Hemostasis and Endothelial Function State in Patients with Stable Coronary Heart Disease
- Changes in Extracellular Matrix Components Metabolism in Patients with Nonalcoholic Steatohepatitis on the Background of Obesity and Comorbidity with Chronic Kidney Disease
- Remodeling of heart in patients with stable ischemic heart disease combined with chronic obstructive pulmonary disease as a basis for development of heart failure
- PROSPECTS OF RIVAROXABAN USE IN THE TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
- ADHERENCE TO TREATMENT IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCORDING TO THE REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA)